Ifp Advisors, Inc Aytu Biopharma, Inc Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.15 - $4.0 $150 - $4,000	1,000 Added 83.33%	2,200 $15,000
Q2 2022 Sep 06, 2022	BUY	$0.46 - $1.08 $552 - $1,296	1,200 New	1,200 $8,000
Q2 2022 Aug 12, 2022	SELL	$0.46 - $1.08 $552 - $1,296	-1,200 Closed	0 $0
Q4 2021 Jan 12, 2022	BUY	$1.35 - $2.95 $810 - $1,770	600 Added 100.0%	1,200 $2,000
Q3 2021 Oct 06, 2021	BUY	$2.78 - $5.12 $1,112 - $2,048	400 Added 200.0%	600 $2,000
Q2 2021 Jul 13, 2021	BUY	$4.73 - $7.56 $946 - $1,512	200 New	200 $1,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.